A dynamic model for COVID-19 therapy with defective interfering particles and artificial antibodies
From MaRDI portal
Publication:6599009
Recommendations
- A delayed dynamical model for COVID-19 therapy with defective interfering particles and artificial antibodies
- On a model of COVID-19 dynamics
- Modeling of COVID-19 using an SEIR model with a saturated incidence rate
- Dynamics of an HIV-1 therapy model of fighting a virus with another virus
- Stability analysis of a delayed immune response model to viral infection
Cites work
This page was built for publication: A dynamic model for COVID-19 therapy with defective interfering particles and artificial antibodies
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6599009)